Publikationen - Prof. Dr. med. Ursula Plöckinger

2016

  • Plöckinger U: Adolescence, Emerging Adulthood, and Problems of Transition; Chapter pg 49-60, Inherited Metabolic Diseases - A Clinical Approach; Editors Hoffmann Dr. G.F, Zschocke Dr J and Nyhan Dr W.L. Springer Verlag. 2016
  • Belmatoug N, Di Rocco M, Fraga C, Giraldo P, Hughes D, Lukina E, Maas M, Maison-Blanche P, Merkel M, Niederau C, Plöckinger U, Richter J, Stulnig T.M, vom Dahl S, Cox T.M: Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe. European Journal of Internal Medicine. 2016
  • Biegstraaten M, Cox T.M, Belmatoug N, Berger M.G, Collin-Histed T, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes D.A, Iversen P.O, Kiewiet A.I, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores G.M, Plöckinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J, Tylki-Szymańska A, Vom Dahl S, Weisz Hubshman M, Zafeiriou D.I, Zimran A, Hollak C.E.M: Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.Blood Cells, Molecules, and Diseases. 2016
  • Stewart F, Harmatz P, Braunlin E, Bentley A, Burton B, Guffon N, Hale S, Johnston T, Kircher S, Kochhar P, Mitchell J, Plöckinger U, Semotok J, Sisic Z:Management of fertility and pregnancy in individuals with mucopolysaccharidosis (MPS). Journal of Inherited Metabolic Disease. 2016
  • Stewart F, Harmatz P, Braunlin E, Bentley A, Burton B, Guffon N, Hale S, Johnston T, Kircher S, Kochhar P, Mitchell J, Plöckinger U, Sisic Z: Pregnancy in individuals with mucopolysaccharidosis (MPS): A case series. Molecular Genetics and Metabolism Reports. 2016
  • Prasad V, Sainz-Esteban A, Arsenic R, Plöckinger U, Denecke T, Pape U.F, Pascher A, Kühnen P, Pavel M, Blankenstein O: Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study. European Journal of Nuclear Medicine and Molecular Imaging. 2016
  • Prasad V, Tiling N, Denecke T, Brenner W, Plöckinger U: Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease. European Journal of Nuclear Medicine and Molecular Imaging. 2016

2015

  • Plöckinger U: Transition von der Kindheit in das Erwachsenenalter bei chronischen Krankheiten. Medizinische Genetik. 2015
  • Htun P, Nee J, Plöckinger U, Eder K, Geisler T, Gawaz M, Bocksch W, Fateh-Mogadhadam S: Fish-free diet in patients with Phenylketonuria is not associated with early atherosclerotic changes and enhanced platelet activation: PLOSOne. 2015
  • Morris D.A, Blaschke D, Krebs A, Canaan-Kühl S, Plöckinger U, Knobloch G, Walter T.C, Kühnle Y, Boldt LH, Kraigher-Krainer E, Pieske B, Haverkamp W: Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease. Int J Cardiovasc Imaging. 2015
  • Plöckinger U, Tiling N, Bosanska L, Temmesfeld-Wollbrueck B, Irlbacher K, Mezger V, Gossing G: Multiple, Successful Pregnancies in Pompe Disease. Journal of Inherited Metabolic Disease. 2015
  • Volz M.S, Nassir M, Treese C, von Winterfeld M, Plöckinger U, Epple H.J, Siegmund B: Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b. BMC Gastroenterology. 2015

2014

  • Plöckinger U: Sozial-politische Aspekte bei angeborenen Stoffwechselkrankheiten und seltenen Krankheiten; Chapter 6 pg 55-64, Angeborene Stoffwechselkrankheiten bei Erwachsenen. Springer Verlag. 2014
  • Rosentraeger M.J, Garbrecht N , Anlauf M, Raffel A, Knoefel W, Berndt U , Plöckinger U, Wiedenmann B , Klöppel G: Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior. Modern Pathology. 2014
  • Karabul N, Skudlarek A, Berndt J, Kornblum C, Kley R.A, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F: Urge incontinence and gastrointestinal symptoms in adult patients with Pompe disease: a cross-sectional Survey. Journal of Inherited Metabolic Disease. 2014
  • Karabul N, Berndt J; Kornblum C, Kley R.A, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F: Pregnancy and Delivery in Women with Pompe Disease. Molecular Genetics and Metabolism. 2014
  • Schöfl C, Honegger J, Droste M, Grussendorf M, Finke R, Plöckinger U, Berg C, Willenberg H.S, Lammert A, Klingmüller D, Jaursch-Hancke C, Tönjes A, Schneidewind S, Flitsch J, Bullmann C, Dimopoulou C, Stalla G, Mayr B, Hoeppner W, Schopohl J: Prevalence of AIP gene mutations in young patients with acromegaly: a register based study. JCEM. 2014

2013

  • Schüller A, Kornblum C, Deschauer M, Vorgerd M, Schrank B, Mengel E, Zoltan L, Gläser D, Young P, Plöckinger U, Schoser B: Diagnose und Therapie des late-onset Morbus Pompe /Glykogenspeichererkrankung Typ 2. Der Nervenarzt. Springer Verlag. 2013
  • Hörsch D, Ezziddin S, Haug A, Gratz K.F, Dunkelmann S, Krause B.J, Schümichen C, Bengel F.M, Knapp W.H, Bartenstein P, Biersack H.J, Plöckinger U, Schwartz-Fuchs S, Baum R.P: Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry. Recent Results Cancer Res. 2013
  • Plöckinger U: Pregnancy In Pompe Disease. BMC Musculoskeletal Disorders. 2013
  • Dilger H.J, Leissner E, Bosanska L, Lampe C, Beck M, Plöckinger U: Illness Perceptions and Clinical Treatment Experiences in Patients with M. Maroteaux-Lamy (Mucopolysaccharidosis Type VI) and a Turkish Migration Background in Germany. PlosONE. 2013

2012

  • Plöckinger U: Medical Therapy of Acromegaly. Int Journal of Endocrinology and Metabolism. 2012
  • Plöckinger U: Diagnosis and treatment of Gastrinomas in Mulitple Endocrine Neoplasia type 1 (MEN-1). Cancers. 2012
  • Begum N, Maasberg S, Plöckinger U, Anlauf M, Rinke A, Pöpperl G, Lehnert H, Izbicki JR, Krausch M, Raffel A, Bürk CG, Hoffmann J, Goretzki PE, Pape UF: Neuroendokrine Tumore des Verdauungstrakts – Daten des deutschen NET-Registers. 2012
  • Hennermann JB, Roloff S, Gellermann J, Vollmer I, Windt E, Plöckinger U, Mönch E, Querfeld U: Chronic Kidney Disease in Adolescent and Adult Patients with Phenylketonuria. 2012
  • Pape U.F, Perren A, Niederle B, Gross D, Gress T, Costa F, Arnold R, Denecke T, Eriksson B, Plöckinger U, Salazar R, Grossman A and all other Barcelona Consensus Conference participants: Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix including Goblet Cell Carcinomas. Neuroendocrinology. 2012
  • Plöckinger U., Hoffmann U., Geese M., Lupp A., Buchfelder M., Flitsch J., Vajkoczy P., Jakob W., Saeger W., Schulz S., Dohrmann C.: DG3173 (Somatoprim), a unique Somatostatin receptor sub-type 2-, 4- and 5-selective analogue, effectively reduces GH-secretion in human growth hormone secreting pituitary adenomas even in Octreotide non-responsive tumours. European Journal of Endocrinology. 2012

2011

  • Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F, Plöckinger U, Papotti M, Sa-lazar R, Pascher A.; ENETS Consensus Guidelines for the Management of Patients with Digestive Neu-roendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms.; Neuroendocrinology.;2011
  • Schopohl J , Strasburger CJ , Caird D , K. Badenhoop K , Beuschlein F , Droste M , Plöckinger U ,Petersenn S for the German Lanreotide Study Group; Efficacy and Acceptability of Lanreotide Autogel®;2011
  • 120 mg at Diff erent Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LAR; Exp Clin Endocrinol Diabetes;2011
  • Schneider HJ, Klotsche J, Wittchen HU, Stalla GK, Schopohl J, Kann PH, Kreitschmann-Andermahr I, Wallaschofski H; German KIMS board and of the DETECT study; Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency.; Clin Endocrinol (Oxf);2011
  • Hartleb S, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Pfützner A, Kann PH; The German KIMS Board & the German KIMS Pharmacogenetics Study Group; Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.; Pharmacogenomics;2011
  • Mengel E, Reinke J, Böttcher T, Tiling N, Plöckinger U, Rolfs A, Beck M. ; Successfull transfer from imiglucerase to velaglucerase alfa for enzyme replacemetn therapy in type 1 Gaucher disease: a case report series; Journal of Inherited Metabolic Disease;2011

2010

  • Plöckinger U; Neuroendokrine Tumore des Gastrointestinal Traktes: Klinik und Diagnostik; Viszeralmedizin;2010
  • Marianne Pavel, Ashley Grossman, Rudolf Arnold, Aurel Perren, Gregory Kaltsas, Thomas Steinmüller, Wouter de Herder, George Nikou, Ursula Plöckinger, Jose Manuel Lopes, Hironobu Sa-sano, John Buscombe, Peter Lind, Dermot O’Toole,Kjell Öberg, and all other Palma de Mallorca Con-sensus Conference Participants; ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors; Neuroendocrinology.;2010
  • Frilling A, Sotiropolous G, Li Y, Plöckinger U; Multimodal Management of neuroendocrine liver metastases; HPB;2010
  • Kim TD, Schwarz M, Nogai H, Grille P,Westermann J, Ursula Plöckinger U,Braun D, Schweizer U, Arnold R, le Coutre Ph; Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia; Thyroid;2010
  • Plöckinger U, Zoran E, Cascon A, Hoffmann MM, Kammel G, Bacher J, Sullivan M, Isermann B, Fischer L, Raffel A, Knoefel WT, Schott M, Baumann T, Schaefer O, Keck T, Baum RP, Milos I, Muresan M, Peczkowska M, Januszewsicz A, Cupisti K, Tönjes A, Fasshauer M, Langrehr J, Wussow von P, Afaimy A, Schlimok G, Lamberts R, Wiech T, Schmid KW, Robledo M, Eng C, Neumann HPH for the VHL-ICT Consortium and the German NET-Registry; Systemic Comparison of sporadic and syndromic pancreatic islet cell tumors; Endocrine Related Cancer;2010

2009

  • Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Re-incke M; Participants of the German Acromegaly Register.; Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register.; Clin Endo-crinol (Oxf).;2009
  • Michael Beck, Olaf Bodamer, Anibh Das, Andreas Gal, Volkmar Gieselmann, Roberto Giugliani, Björn Hoffmann, Christina Lampe, Thorsten Marquardt, Gerhard Nitz, Ursula Plöckinger, Michael Schlander, Mikaela Weigl, Philipp Wol.; Maroteaux-Lamy syndrome or mucopolysaccharidosis VI: di-agnosis, treatment and future perspectives; OCIM International (Opinions on Current Issues in Medi-cine);2009
  • Plöckinger U, Wiedenmann B, de Herder WW. ; ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors. ; Neuroendocrinology.;2009
  • Akerström G, Falconi M, Kianmanesh R, Ruszniewski P, U. Plöckinger. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in pa-tients with neuroendocrine tumors. ; Neuroendocrinology.;2009
  • Arnold R, Chen YJ, Costa F, Falconi M, Gross D, Grossman AB, Hyrdel R, Kos-Kudła B, Sala-zar R, Plöckinger U. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.; Neuroendocrinology.;2009
  • Plöckinger U, Gustafsson B, Ivan D, Szpak W, Davar J;. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography. ; Neuroendocrinology.;2009
  • Eriksson B, Annibale B, Bajetta E, Mitry E, Pavel M, Platania M, Salazar R, Plöckinger U. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.; Neuroendocrinology;2009
  • Kwekkeboom DJ, Krenning EP, Lebtahi R, Komminoth P, Kos-Kudła B, de Herder WW, Plöck-inger U. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.; Neuroendocrinology; 2009
  • Kwekkeboom DJ, Krenning EP, Scheidhauer K, Lewington V, Lebtahi R, Grossman A, Vitek P, Sundin A, Plöckinger U. ; ENETS Consensus Guidelines for th Standards of Care in Neuroendocrine Tumors: Somatostatin receptor imaging with (111)In-pentetreotide. ; Neuroendocrinology; 2009
  • O’Toole D, Grossman A, Gross D, Della Fave G, Barkmanova J, O'Connor J, Pape U-F, Plöck-inger U. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: bio-chemical markers. ; Neuroendocrinology; 2009
  • Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M, Rindi G, Plöckinger U. ; ENETS Consensus Guidelines for the Stan-dards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastro-enteropancreatic neuroendocrine tumors and their prognostic stratification.; Neuroendocrinology; 2009
  • Oberg K, Ferone D, Kaltsas G, Knigge UP, Taal B, Plöckinger U. ; ENETS Consensus Guide-lines for the Standards of Care in Neuroendocrine Tumors: biotherapy.; Neuroendocrinology; 2009
  • Sundin A, Vullierme MP, Kaltsas G, Plöckinger U. ; ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations ; Neuroendocrinology.; 2009
  • Schott, M, Wiedenmann B, Plöckinger U; Neuroendokrine Tumore des Gastrointestinaltrakts; In: Lehnert H(ed): Rationelle Diagnositk und Therapie in der Endokrinologie; 2009
  • Plöckinger U; Neuroendokrine Tumore des Gastrointestinal Traktes; In: Schmoll HJ, Arnold D (eds), Therapiekonzepte bei gastrointestinalen Tumoren; 2009
  • Buchfelder M, Weigel D, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Bidlingmaier M, Strasburger CJ; Investigators of German Pegvisomant Observational Study.; Pituitary tumor size in ac-romegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegviso-mant Observational Study.; European Journal of Endocrinology; 2009
  • Fateh-Moghadam, S, Reuter T, Htun P, Schartl M, Plöckinger U, Dietz R, Bocksch W. ; Stress echocardiography for risk stratification of asymptomatic patients with type 2 diabetes mellitus.; Inter-national Journal of Cardiology; 2009
  • Plöckinger U, Klöppel G, Wiedemann B, Lohmann R; The German Net Registry: An Audit on the Diagnosis and therapy of Neuroendocrine Tumours; Neuroendocrinology; 2009
  • Zoran Erlic, Lisa Rybicki, Mariola Peczkowska, Henriette Golcher Peter H. Kann, Michael Brauckhof Karsten Müssig, Michaela Muresan, Andreas Schäffler, Nicole Reisch, Matthias Schott, Martin Fassnacht, Giuseppe Opocher, Silke Klose, Christian Fottner, Flavio Forrer, Ursula Plöckinger, Stephan Petersenn, Dimitry Zabolotny, Andrzej Januszewicz, Martin Walz, Charis Eng, and Hartmut P.H. Neumann; Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Pa-tients; Clinical Cancer Research; 2009
  • Meyer S, Schaefer S, Stolk L, Arp P, Uitterlinden AG, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH; The exon 3-deleted/full-length growth hormone receptor (GHRd3/fl) polymorphism determines recombinant GH-dose in GH-deficient adults; Pharma-cogenomics; 2009
  • Fateh-Mogadhadam S, Nee J, Moench N, Sari K, Moench E, Plöckinger U, Eder K, Dietz R, Boksch W.; Low Phenylalanin diet with the restriction of natural protein is not associated with early atherosclerotic changes and enhanced platelet activiation in patients with phenylketonuria (PKU); Ar-terioscler Thromb Vasc Biol.; 2009
  • Plöckinger U, Topuz M, Langer M, Reuter T.; Problems of Diabetes Management in the Immi-grant Population in Germany; Diabetes Research and Clinical Practice

2008

  • Plöckinger U.; Das deutsche Register für neuroendokrine Tumore; Glandula NETPlöckinger U. ; BBGN, Nuklearmedizin, Information, Berlin Brandenburg, 'Schilddrüsenkarzi-nom - Neue Therapieansätze'; BBGN Nuklearmedizin 23/2008; 2008
  • Plöckinger U., Couvelard A., Falconi M., Sundin A., Salazar R., Christ E., de Herder W., Gross D., Knapp w., Knigge U.-P., Kuhlke M., Pape U.-F., all other Frascati Consensus Conference partici-pants; Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-differentiated Tumour/Carcinoma of th eAppendix and Goblet-Cell Carcinoma.; Neuroendocrinology; 2008
  • Eriksson B, Kloppel G, Krenning E, Ahlman H, Plöckinger U, Wiedenmann B. ; Consensus guidelines for the management of patients with digestive neuroendocrine tumours- well-differentiated jejunal –ileal tumor/carcinoma. ; Neuroendocrinology; 2008
  • Plöckinger U.; Chapter 23: Biotherapy and Chemotherapy of Gastrointestinal Neuroendocrine Tumours. MDT Approach to Neuroendocrine Tumours.; In: Plöckinger U, Wiedenmann B (eds) GI On-cology – A critical MDT Approach. ; 2008
  • Plöckinger U., Reuter, T.,; Pegvisomant does not improve insulin sensitivity but increases intra-abdominal fat in patients with acromegaly – a pilot study; Eur J Endocrinol; 2008
  • Garbrecht N, Anlauf M, Schmitt A, Henopp T, Sipos B, Raffel A, Eisenberger CF, Knoefel WT, Pavel M, Fottner C, Musholt TJ, Rinke A, Arnold R, Berndt U, Plöckinger U, Wiedenmann B, Moch H, Heitz PU, Komminoth P, Perren A, Klöppel G.; Somatostatin -producing neuroendocrine tumours of the duodenum and pancreas: incidence, types , biological behaviour, association with inherited syn-dromes, and functional activity.; Endocrine-Related Cancer; 2008
  • S. Meyer, S. Schaefer, D. Ivan, L. Stolk, P. Arp, A. J. van der Lely, A. G. Uitterlinden, J. R. Ittner, P. P. Nawroth, U. Plöckinger, G. K. Stalla, U. Tuschy, M. M. Weber, A. Weise, A. Pfützner, P. H. Kann ; Growth hormone (GH)-dose in GH-deficient adults is not associated with IGF-1 gene polymor-phisms; Pharmacogenomics; 2008
  • Meyer S, Haist M, Ivan D, Ittner JR, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH. ; Influence of the COLIA1 Sp1 polymorphism on the biological ef-fect of subcutaneously injected recombinant growth hormone (GH) in GH-deficient adults; Pharmaco-genomics; 2008
  • Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann, R, Quabbe H-J, Plöckinger U; Results of surgical and somatostatin analogue therapy and their combination in ac-romegaly – A Retrospective Analysis of the German Acromegaly Register ; European J Endocrinology; 2008
  • Plöckinger U, Topuz M, Riese R, Reuter, T.; Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: Comparison of insulin glargine with NPH insulin as basal insulin supplement. ; Diabetes Research and Clinical Practice; 2008
  • Plöckinger U, Albrecht S, Mawrin C, Saeger W, Buchfelder M, Petersenn S, Schulz S.; Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant GH Secreting Adenomas; JCE; 2008

2007

  • Plöckinger U.; Neuroendokrine gastrointestinale Tumoren; UNI-MED Verlag, Bremen; 2007
  • Plöckinger U , Wiedenmann B. ; Treatment of gastroenteropancreatic neuroendocrine Tumours; In: Klöppel G (ed) Gastroenteropancreatic and pulmonary neuroendocrine tumores: an update.; 2007
  • Pascher A, Plöckinger U.; Palliative Leberchirurgie inklusive ablativer Verfahren.; Neuroendo-krine Tumore.; 2007
  • Plöckinger U.;, Wiedenmann B. ; Biotherapy. ; In: Öberg K, Eriksson B (eds) Neuroendocrine Tumours.; 2007
  • Plöckinger U. ; Medikamentöse Therapie neuroendokriner gastrointestinaler Tumore. ; In: Plö-ckinger U (Ed) Neuroendokrine gastrointestinale Tumore. Reihe Uni-Med Science.; 2007
  • Plöckinger U. ; Diagnosis and treatment of gastric neuroendocrine tumours. ; In: Wiedenmann B, Niederle B (eds) Hypergastrinemia – Diagnosis and Treatment.; 2007
  • Göncz, E., Strowski, Z., Grötzinger, C., Nowak K., Kaczmarek, P., Sassek, M., Mergler, S., El-Zayat, Theodoropoulou, M., Stalla, G., Wiedenmann, B., Plöckinger U., ; Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway; Endocrinology; 2007
  • Singh V, Grotzinger C, Nowak KW, Zacharias S, Goncz E, Pless G, Sauer IM, Eichhorn I, Pfeif-fer-Guglielmi B, Hamprecht B, Wiedenmann B, Plöckinger U, Strowski MZ.; Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyerpglycemia, non-fasting hyperglucagonemia and decreased hepatic glycogen deposition. ; Endocrinology; 2007
  • Plöckinger U, Krüger D, Bergk A, Weich V, Wiedenmann B, Berg T. ; Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-α. ; American J. of Gastroenterology.; 2007
  • Mergler S, Strowski M, Kaiser S, Plath T, Plöckinger U, Wiedenmann B, Grötzinger C. ; Tran-sient Receptor Potential Channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in Neuroendocrine Tumour Cells. ; Neuroendocrinology; 2007
  • Langrehr J, Bahra M, Kristiansen G, Neumann HPH, Neumann LM, Plöckinger U, Lopez-Hänninen E.; Neuroendocrine tumour of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood.; Pediatric Surgery; 2007
  • Bahra M, Jacob D, Pascher A, Plöckinger U, Kristiansen G, Neuhaus P, Langrehr JM. ; Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas. ; J Gastro-enterology Hepatology; 2007
  • Meyer S, Weber M, Tuschy U, Stalla g, Plöckinger U, Nawroth P, Weise A, Minnemann T, Keth A, Ipek M. von Mach M, Kann P. ; Short stature and decreased insulin-like growth factor (IGF-I)/growth hormone (GH) ratio in an adult GH-deficient patient pointing to additional partial GH-insensivity due to a R179C mutation ot the growth hormone receptor. ; Growth Horm IGF Res.; 2007

2006

  • Falconi M, Plöckinger U, Kwekkeboom DJ, Manfredi R, Körner M, Kvols L, Pape UF, Ricke J, Goretzki PE, Wildi S, Steinmüller T, Öberg K, Scoazec JY, et al. ; Well-Differentiated Pancreatic Non-functioning Tumors/Carcinoma. ; In: De Herder W, O’Toole D, Rindi G, Wiedenmann B (eds) ENETS Consensus Guidelines for the Management of Patients wirth Digestive Neuroendocrine Tumors Part 1- Stomach, Duodenum and Pancreas.; 2006
  • Plöckinger U. ; Neuroendokrine Tumoren des Gastrointestinaltraktes. ; Up2date.; 2006
  • Plöckinger U. ; ENETS Guidelines for diagnosis and therapy of neuroendocrine gastrointestinal tumors. ; In: Neuroendocrine Tumors: Diagnostics and therapeutic approach.; 2006
  • Singh V, Brendel MD, Zacharias S, Mergler S, Jahr H, Wiedenmann B, Bretzel RG, Plöckinger U, Strowski Z. ; Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion-an in vitro study ond isolated human pancreatic islets. ; JCEM; 2006

2005

  • Plöckinger U. ; Leitlinien Akromegalie. ; DGE; 2005
  • Pape UF, Plöckinger U, Wiedenmann B. ; Neuroendokrie Tumoren des gastroenteropankreati-schen Systems. ; Journal of Pedriatic Surgery (ELSEVIER); 2005
  • Plöckinger U, Wiedenmann B. ; Management of metastatic endocrine tumours. ; In: Arnold R (ed), Endocrine Tumours of the Gastrointestinal Tract: Part I; 2005
  • Plöckinger U, Quabbe HJ. ; Acromegaly: Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A Long-term case-control study. ; Acta Neurochirurgica.; 2005
  • Mergler S, Strauss O, Strowski M, Prada J, Drost A, Langrehr J, Neuhaus P, Wiedenmann B, Plöckinger U. ; Insulin-Like Growth Factor-1 Increases Intracellular Calcium Concentration in Hu-man Primary Neuroendocrine Pancreatic Tumour Cells and a Pancreatic Neuroendocrine Tumour Cell Line (BON-1) via R-Type CA 2+ Channels and Regulates Chromogranin A Secretion in B; Neuroendo-crinology.; 2005
  • Fateh-Moghadam S, Plöckinger U, Cabeza N, Htun P, Reuter T, Ersel S, Gawaz M, Dietz R, Bocksch W. ; Prevalence of Aspirin Resistance in Patients with Type 2 Diabetes. ; Acta Diabetologica.; 2005
  • Fateh-Moghadam S, Li Z, Ersel S, Reuter T, Htun P, Plöckinger U, Bocksch W, Dietz R, Gawaz M. ; Platelet degranulation is associated with progression of intima-media thickness of the common ca-rotid artery in patients with diabetes mellitus type 2. ; Arterioscler Thromb Vasc Biol.; 2005
  • Amthauer H, Denecke T, Rohlfing T, Ruf J, Bohmig M, Gutberlet M, Plöckinger U, Felix R, Lemke AJ. ; Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendo-crine tumours. ; Eur Radiol.; 2005

2004

  • Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Wiedenmann B. ; Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tu-mours. ; A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).; 2004
  • Plöckinger U, Wiedenmann B. ; Diagnosis of nonfunctioning neuroendocrine gastro-enteropancreatic Tumours.; 2004
  • Plöckinger U, Wiedenmann B. ; Therapiealgorithmen neuroendokrinen Tumoren des Gastroin-testinaltraktes; In: Wiedenmann B, Rothmund M, Molls M (eds), Neuroendokrine Tumoren (Teil 2). ; 2004
  • Plöckinger U, Wiedenmann B. ; Neuroendokrine Tumoren des Gastrointestinaltraktes; 2004
  • Plöckinger U, Wiedenmann B. ; Diagnostische Algorithmen bei neuroendokrinen Tumoren des gastroenteropankreatischen Systems. ; In: Wiedenmann B, Rothmund M, Molls M (eds), Neuroendo-krine Tumoren.; 2004
  • Plöckinger U, Wiedenmann B. ; Biotherapie neuroendokriner gastrointestinaler Tumore. ; In: Wiedenmann B, Rothmund M, Molls M (eds), Neuroendokrine Tumoren.; 2004
  • Plöckinger U. ; Therapie bei hypophysärer Akromegalie. ; Forschung und Praxis. ; 2004
  • Pape UF, Böhmig M, Berndt U, Tiling N, Wiedenmann B, Plöckinger U, ; Survival and Clinical Outcome of Patients with Neuroendocrine Tumours of the Gastroenteropancreatic Tract in a German Referral Centre. ; AnnNYAS; 2004
  • Amthauer H, Ruf J, Böhmig M, Lopez-Hanninen E, Rohlfing T, Wernecke KD, Plöckinger U, Gutberlet M, Lemke AJ, Steinmuller T, Wiedenmann B, Felix R. ; Diagnosis of neuroendocrine tu-mours by retrospective image fusion: is there a benefit?. ; Eur J Nucl Med Mol Imaging. ; 2004

2003

  • Lehnert H, Becker W, Dralle H, Plöckinger U, Wiedenmann B. ; Neuroendokrine Tumoren des Gastrointestinaltrakts. ; In: Lehnert H (ed), Rationelle Diagnostik und Therapie in Endokrinologie, Di-abetologie und Stoffwechsel.; 2003
  • Plöckinger U. ; Pathogenes der somatotropen Adenome. ; In: Quabbe HJ (ed), Interdisziplinäres Vorgehen bei Akromegalie und Gigantismus. ; 2003
  • Plöckinger U.; Präoperative Therapie der Akromegalie mit einem Somatostatinanalogon. ; In: Quabbe HJ (ed), Interdisziplinäres Vorgehen bei Akromegalie und Gigantismus. ; 2003
  • Plöckinger U.; Medikamentöse Therapie der Akromegalie. ; In: Quabbe HJ (ed), Interdisziplinä-res Vorgehen bei Akromegalie und Gigantismus. ; 2003
  • Plöckinger U.; Betreuung von Patienten mit hormoninaktiven Adenomen der Hypophyse: Medi-kamentöse und antiproliferative Therapie. Zusammenfassung der Ergebnisse einer Expertenkonferenz im Auftrag der Arbeitsgemeinschaft Hypophyse der Deutschen Gesellschaft für Endokrinologie, Frie-dewald, 15-17 Februar 2002.; Medizinische Klinik. ; 2003

2002

  • Strasburger CJ, Jaursch-Hancke C, Kann PH, Klingmüller D, Plöckinger U, Petersenn S, Quabbe HJ. ; Missbräuchlicher Einsatz von humanem Wachstumshormon in der Anti-Aging-Medizin. ; Deut-sches Ärzteblatt.; 2002
  • Plöckinger U, Wiedenmann B. ; Neuroendocrine tumors of the gastro-entero pancreatic GEP system : The role of early diagnosis, genetic testing and preventive surgery. ; Digestive Diseases.;2002
  • Plöckinger U, Wiedenmann B. ; Treatment of non-functioning gastroenteropancreatic tumors. ; In: Lamberts SWJ, Dogliotti L (eds), The Expanding Role of Octreotide I: Advances in Oncology.; 2002
  • Linzcak G, Duschek M, Tempka A, Plöckinger U, Dietel M.; Med. Dokumentationsassitentinnen zur Unterstützung stationärer Ablaufprozesse. ; Krankenhaus Umschau; 200

1989 - 2001

  • Plöckinger, U; Akromegalie: Eine Anaylse der therapeutischen Optionen und Erfolge; Habilita-tionsschrift; 2001
  • Plöckinger U. ; Diabetes mellitus- State of the Art in der ambulanten Behandlung. ; Klinik und Forschung.; 2000
  • Plöckinger U Wiedenmann B. ; Das Phäochromozytom.; In: Der Onkologe.; 2000
  • Pape UF, Toliat MR, Berger W, Ropers HH, Plöckinger U, Wiedenmann B. ; Multiple endocrine neoplasia type 1: a familial cancer syndrome and its genetics. ; Oncology in Practice.; 1999
  • Plöckinger U,Holst JJ, Messerschmidt D, Hopfenmüller W, Quabbe H-J. ; Octreotide sup-presses the invretin glucagon-like peptide(7-36) amide in patients with acromegaly or clinically non-functioning pituitary tumours and in healthy subjects. ; Eur J Endocrinol; 1999
  • Fehn M, Sommer C, Lüdecke DK, Plöckinger U, Saeger W. ; Lymphocytic Hypophysitis: Light and Electron Microscopic Findings and Correlation to Clinical Appearance. ; Endocrine Pathology.; 1998
  • Mayenknecht J, Diederich S, Bähr V, Plöckinger U, Oelkers W. ; Comparison of Low and High Dose Corticotrophin Stimulation Tests in Patients with Pituitary Disease. ; JCEM; Published; 1998
  • Plöckinger U, Perez-Canto A, Emde C, Liehr RM, Hopfenmüller W, Quabbe H-J. ; Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preopera-tive treatment in patients with acromegaly. ; Eur J Endocrinol; 1998
  • Plöckinger U, Bäder M, Hopfenmüller W, Saeger W, Quabbe H J. ; Results of Somatostatin-Receptor Scintigraphy Do Not Predict Pituitary Tumour Response to Octreotide Therapy and Do Not Correlate with Tumour Histology. ; Eur J Endocrinol; 1997
  • Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe H-J. ; Preoperative Octreotide Treatment of Growth Hormone-Secreting and Clinically Nonfunctioning Pituitary Macro adenomas: Effect on Tu-mour Volume and Lack of Correlation with Immunohistochemistry and Somatostatin Receptor Scinti-graphy. ; JCEM; 1994
  • Plöckinger U, Liehr R-M, Quabbe H-J. ; Octreotide Long Term Treatment of Acromegaly: Effect of Drug Withdrawal on Serum Growth Hormone/IGF-I Concentrations and on Serum Gastrin/24-h In-tragastric pH-Values. ; JCEM; 1993
  • Plöckinger U, Quabbe H-J. ; Evaluation of a Repeatable Depot-Bromocroptine Preparation (Parlodel LAR®) for the Treatment of Acromegaly. ; J Endocrinol Invest.; 1991
  • Plöckinger U, Dienemann D, Quabbe H-J. ; Gastrointestinal Side-Effects of Octreotide During Long Term Treatment of Acromegaly. ; JCEM; 1990
  • Quabbe H-J, Plöckinger U. ; Dose-Response Study and Long Term Effect of the Somatostatin Analogue Octreotide in Patients with Therapy-Resistant Acromegaly. ; JCEM; 1989